Stomach cancer

Where the papers sit

14 papers from the last 6 months study stomach cancer directly · updated from PubMed 20 Oct 2026

• Gastric Cancer Molecular Biology

  Gastric cancer biology is being linked to Helicobacter pylori, host genetics, the microbiome, telomere regulation, stem-cell programs, and prognostic gene networks. Ferroptosis, including FTL-mediated vulnerability, is emerging alongside platinum-based strategies as a therapeutic target. Prostate stem cell antigen and other stemness-related factors recur as markers of risk or tumor behavior. The work is moving toward integrated models that connect etiology, cellular state, prognosis, and treatment response.

  5 papers · 35.7%

• Perioperative Therapy in Gastric Cancer

  Perioperative treatment is being refined through FLOT induction, neoadjuvant chemoradiotherapy, systemic therapy, and surgical resection. ASTRUM-006 reflects the expanding role of newer systemic regimens in the treatment landscape. Patient-derived organoids are being positioned to support precision selection of therapy, while schizophrenia-spectrum illness highlights unequal access to invasive and systemic treatment. The open question is how to sequence these approaches and identify patients most likely to benefit.

  4 papers · 28.6%

• Others — Gastric Cancer Clinical Research

  Gastric cancer research here ranges from postoperative quality of life and education tools to radiomics, extracellular-vesicle biomarkers, and computational circRNA associations. Accuracy, validation, and clinical relevance recur across these applications. The work is moving toward more noninvasive diagnosis and more usable patient support, but no single biological or clinical direction unifies the set. Their shared focus is assessment around gastric cancer rather than one defined research question.

  5 papers · 35.7%